Skip to main content
Clinical Trials/NCT03673514
NCT03673514CompletedNot Applicable

Direct Anterior Versus Posterior Approach for Total Hip Arthroplasty: a Multicentric Prospective Randomized Clinical Study

Hopital du Sacre-Coeur de Montreal0 sites50 target enrollmentStarted: February 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Primary Endpoint
Hospital stay

Study Overview

Brief Summary

Determining the best approach for a total hip arthroplasty (THA) implies that the procedure is kind on soft tissues, with the lowest complication rates, and easily reproducible. Although there have been several attempts to resolve this issue in the last decade, a definitive answer has not been found. Therefore, the investigators performed a prospective study to compare direct anterior versus posterior approach based on (1) hospital stay, (2) functional outcome, (3) pain, (4) implant position (5) complications and (6) surgical time.

Detailed Description

In this multicentric, prospective, randomized clinical trial, 55 total hip arthroplasties were performed on 50 patients between February 2011 and July 2013. Patients meeting the inclusion criteria underwent surgical treatment using the DAA or PA, according to a randomization process. Radiological analysis assessed implant position, limb lengthening, and potential implant related complications. X-rays were performed at subsequent follow-up visits and consisted of an antero-posterior (AP) pelvic X-ray and a lateral projection of the hip. Two independent observers, not involved with patients or surgeries, reviewed all postoperative radiographs independently.Two fellowship-trained surgeons in two separate hospitals performed all procedures. Both surgeons had previously performed over 100 cases with each approach, before initiating this study.

Patients underwent either the posterior or direct anterior approach.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

However, the decision to discharge subjects was made by physiotherapists blinded to treatment and based on objective criteria. These criteria were: 1) being autonomous for transfer from bed/chair to upright position 2) being able to walk with walking aid 3) climbing stairs in a safe way 4) having a pain level contained by painkillers. No restrictions were recommended for either group. The same rehabilitation and pain protocols were used for both approaches. In addition, statistical analyses were performed by an independent consultant who remained blinded to treatment group assignment.

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •primary total hip replacement due to osteoarthrosis or osteonecrosis
  • •patients older than 50 years.

Exclusion Criteria

  • •inflammatory arthritis,
  • •any previous ipsilateral hip surgery
  • •suffering from proximal femoral deformity
  • •BMI over 40
  • •active infection
  • •severe contralateral hip disease, muscle contractures or neuromuscular pathology
  • •requiring structural bone grafts.

Arms & Interventions

THA Posterior Approach

Active Comparator

The posterior approach to the hip has been described by many authors and yields good results. Implants used were Quadra®-H stem and Versacup® hip system, Medacta, Switzerland, with metal on polyethylene bearing. All implants were non-cemented.

Intervention: Total hip arthroplasty (Procedure)

THA Direct anterior approach

Active Comparator

The modified Hueter approach, based on the Smith-Peterson approach, was performed for the direct anterior minimally invasive surgery. This approach could have some advantages as it is a muscle sparing approach, hence yielding a faster recovery. A traction table was used for DAA as surgeons were trained to use this method. No intra-operative fluoroscopy was used for implant confirmation.Implants used were Quadra®-H stem and Versacup® hip system, Medacta, Switzerland, with metal on polyethylene bearing. All implants were non-cemented.

Intervention: Total hip arthroplasty (Procedure)

Outcomes

Primary Outcomes

Hospital stay

Time Frame: Between 0 days and 1 month, average of 4 days

Length in days of hospital stay

Secondary Outcomes

  • implant position(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • functional recovery(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • pain assessment: VAS(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • number of patients with per/post surgical complications.(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • surgical time(Up to 240 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kevin Moerenhout

Orthopedic Surgeon

Hopital du Sacre-Coeur de Montreal

Similar Trials